Suppr超能文献

疫苗政策从口服脊髓灰质炎疫苗改为灭活脊髓灰质炎疫苗前后急性弛缓性麻痹监测病例的病毒病因学

Viral Aetiology of Acute Flaccid Paralysis Surveillance Cases, before and after Vaccine Policy Change from Oral Polio Vaccine to Inactivated Polio Vaccine.

作者信息

Saraswathy Subramaniam T S, Apandi Mohd Apandi, Jahis Rohani, Samsudin Mohd Samsul, Saat Zainah

机构信息

Virology Unit, Institute for Medical Research, Jalan Pahang, 50588 Kuala Lumpur, Malaysia.

Surveillance Unit, Disease Control Division, Ministry of Health, Level 6, Block E10, 62590 Putrajaya, Malaysia.

出版信息

J Trop Med. 2014;2014:814908. doi: 10.1155/2014/814908. Epub 2014 Mar 19.

Abstract

Since 1992, surveillance for acute flaccid paralysis (AFP) cases was introduced in Malaysia along with the establishment of the National Poliovirus Laboratory at the Institute for Medical Research. In 2008, the Ministry of Health, Malaysia, approved a vaccine policy change from oral polio vaccine to inactivated polio vaccine (IPV). Eight states started using IPV in the Expanded Immunization Programme, followed by the remaining states in January 2010. The objective of this study was to determine the viral aetiology of AFP cases below 15 years of age, before and after vaccine policy change from oral polio vaccine to inactivated polio vaccine. One hundred and seventy-nine enteroviruses were isolated from the 3394 stool specimens investigated between 1992 and December 2012. Fifty-six out of 107 virus isolates were polioviruses and the remaining were non-polio enteroviruses. Since 2009 after the sequential introduction of IPV in the childhood immunization programme, no Sabin polioviruses were isolated from AFP cases. In 2012, the laboratory AFP surveillance was supplemented with environmental surveillance with sewage sampling. Thirteen Sabin polioviruses were also isolated from sewage in the same year, but no vaccine-derived poliovirus was detected during this period.

摘要

自1992年起,马来西亚开始对急性弛缓性麻痹(AFP)病例进行监测,并在医学研究所设立了国家脊髓灰质炎病毒实验室。2008年,马来西亚卫生部批准了疫苗政策从口服脊髓灰质炎疫苗改为灭活脊髓灰质炎疫苗(IPV)。八个州开始在扩大免疫规划中使用IPV,其余州于2010年1月开始使用。本研究的目的是确定在疫苗政策从口服脊髓灰质炎疫苗改为灭活脊髓灰质炎疫苗之前和之后,15岁以下AFP病例的病毒病因。在1992年至2012年12月期间调查的3394份粪便标本中分离出179株肠道病毒。107株病毒分离株中有56株为脊髓灰质炎病毒,其余为非脊髓灰质炎肠道病毒。自2009年在儿童免疫规划中相继引入IPV后,未从AFP病例中分离出萨宾脊髓灰质炎病毒。2012年,实验室AFP监测通过污水采样进行环境监测得到补充。同年还从污水中分离出13株萨宾脊髓灰质炎病毒,但在此期间未检测到疫苗衍生脊髓灰质炎病毒。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c579/3977537/63cc09fb2c4e/JTM2014-814908.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验